May 04, 2017
![](http://cdn-test.sipr.ucl.ac.be/styles/full_content/groups/cms-editors-ldri/imagessites/emily_CATRY_MNUT_avril2017.jpg?itok=0prA1i-c)
Emilie Catry
(Metabolism and Nutrition, LDRI, UCL) / promotor: N. Delzenne
Role of the gut microbiota in the control of cardio-metabolic risk
Related publications:
° Catry et al. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut. 2017 Apr 4. pii: gutjnl-2016-313316. doi: 10.1136/gutjnl-2016-313316.
° Catry et al. Nutritional depletion in n-3 PUFA in apoE knock-out mice: A new model of endothelial dysfunction associated with fatty liver disease. Mol Nutr Food Res. 2016 Oct;60(10):2198-2207.
° Catry et al. Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sci. 2015 Jul 1;132:77-84.